By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:


SEARCH JOBS




Collaborations

ACADIA Pharmaceuticals, Inc.  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Cubist Pharmaceuticals, Inc. 





Company News
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution 10/1/2014 5:53:07 AM
Sunovion Pharmaceuticals Inc. Announces Data Published In The CHEST Journal From A One-Year, Large Simple Safety Study Evaluating BROVANA® (Arformoterol Tartrate) Inhalation Solution 7/8/2014 7:21:21 AM
FDA Slashes Starting Dose For Sunovion Pharmaceuticals Inc.'s Lunesta; Warns Risk Of Next-Day Impairment 5/15/2014 3:17:45 PM
Sunovion Pharmaceuticals Inc. Release: Once-Daily Aptiom® (Eslicarbazepine Acetate) For The Adjunctive Treatment Of Partial-Onset Seizures Now Available In U.S. Pharmacies 4/7/2014 10:15:05 AM
Sunovion Pharmaceuticals Inc. And Takeda Announce Results From A New Study Showing Maintenance Treatment With Lurasidone Reduced The Risk Of Relapse In Adults With Schizophrenia 3/3/2014 8:36:35 AM
Sunovion Pharmaceuticals Inc. Presents Positive Results From Two Phase 3 Studies Of Once-Daily Aptiom® (Eslicarbazepine Acetate) As Monotherapy Treatment For Partial-Onset Seizures 12/9/2013 10:02:58 AM
Sunovion Pharmaceuticals Inc. Presents Phase 3 Pooled Analysis Of Once-Daily Aptiom® (Eslicarbazepine Acetate) As Adjunctive Treatment For Partial-Onset Seizures 12/9/2013 10:01:54 AM
Sunovion Pharmaceuticals Inc. To Present New Data On Aptiom® (eslicarbazepine acetate) At The American Epilepsy Society’s 67th Annual Meeting 12/9/2013 7:15:26 AM
Sunovion Pharmaceuticals Inc.., The COPD Foundation And Caring.com Join Forces To Support COPD Family Caregivers 11/18/2013 10:01:09 AM
Sunovion Pharmaceuticals Inc. Announces Publication of Two Pivotal Studies Supporting FDA Approval of Latuda® (lurasidone HCl) as Monotherapy and Adjunctive Therapy in Adult Patients With Bipolar Depression in The American Journal of Psychiatry 11/1/2013 9:50:42 AM
12345678910...
//-->